Summary
Biogen Idec Inc. (BIIB) filed an 8-K on July 2, 2007, detailing the establishment of significant new credit facilities. The company secured a $1.5 billion senior term loan facility, which was fully drawn on July 2, 2007, to support an aggregate share repurchase of approximately $3 billion via a modified Dutch Auction tender offer. This term loan matures on June 26, 2008. Additionally, Biogen Idec established a $400 million revolving credit facility, available for general corporate purposes, working capital, and letters of credit, with a maturity in June 2012. While no funds are currently drawn under the revolving facility, it provides future financial flexibility.
Key Highlights
- 1Biogen Idec secured a $1.5 billion senior term loan facility, fully drawn to fund a significant share repurchase program.
- 2A $400 million revolving credit facility was established for ongoing corporate needs, offering financial flexibility.
- 3The term loan has a short maturity of approximately one year (June 26, 2008), indicating its use for a specific, near-term financing event.
- 4The revolving credit facility matures in June 2012, providing longer-term access to funds.
- 5Interest rates are variable, based on LIBOR or a Base Rate, plus an applicable rate tied to the company's debt ratings.
- 6Both facilities include customary covenants, such as financial ratios (leverage and interest coverage) and negative covenants restricting certain corporate actions.
- 7Events of default include payment failures, covenant breaches, bankruptcy, and change of control, allowing lenders to accelerate debt.
Frequently Asked Questions
The $1.5 billion senior term loan was fully drawn to fund a substantial share repurchase program, part of a modified Dutch Auction tender offer that aimed to return approximately $3 billion to shareholders.
The revolving credit facility is designed to provide Biogen Idec with financial flexibility for working capital requirements, letters of credit, and other general corporate purposes. The company can borrow, repay, and re-borrow funds under this facility as needed.
The $1.5 billion term loan matures on June 26, 2008, making it a short-term financing tool. The $400 million revolving credit facility matures on June 29, 2012, offering longer-term access to funds. Interest rates are variable and depend on debt ratings.
Yes, both facilities contain customary covenants. These include financial covenants such as a total leverage ratio and an interest coverage test, as well as negative covenants that restrict the company's ability to incur additional debt, engage in certain transactions, and enter into affiliate transactions. There are also standard representations, warranties, and events of default.